The San Diego Union Tribune covers Okogen’s receival of $10 million in Series A funding to further invest in treatments for viral conjunctivitis.
Read more here.
© 2021 Okogen, Inc. All Rights Reserved
Okogen, Inc.332 Encinitas Blvd. Suite 102Encinitas, CA 92024, USA
Okogen Pty Ltd Level 9, 31 Queen St Melbourne, VIC 3000 AUS